When a patient on MTP develops a lengthening QT and blood pressure worsens, citrate-mediated hypocalcemia should move high on the list—but the monitor does not prove it is the only problem. The ED task is to confirm and correct the calcium deficit while blood products, hemorrhage control, and the search for other causes of shock continue in parallel. The common miss is treating the deterioration as only more bleeding and overlooking a reversible transfusion complication.
Why citrate becomes a hemodynamic problem
Citrate is added to blood products to prevent clotting in the bag. Once transfused, it binds circulating ionized calcium—the fraction available for immediate physiologic work. Citrate is normally metabolized rapidly, especially by a well-perfused liver. During rapid transfusion, the citrate load can outpace clearance; hemorrhagic shock, poor tissue perfusion, or liver dysfunction can make that imbalance worse.
Calcium supports myocardial contraction, vascular tone, and several steps in coagulation and platelet function. When ionized calcium falls, cardiac contraction and systemic vascular resistance may weaken, and clot formation can be impaired. Low calcium can prolong the ST segment and therefore the QT interval, but a prolonged QT is a clue—not a stand-alone diagnosis.
Use the right signal: ionized calcium
Check ionized calcium promptly, often from a blood-gas analyzer, and interpret it alongside the pH. Alkalemia can lower the ionized fraction even when total calcium has not changed. A commonly cited normal ionized-calcium range is about 1.1–1.3 mmol/L; trauma guidance recommends prompt correction when it falls below 0.9 mmol/L and maintaining it in the normal range.
| Finding | What it tells you—and what to do |
|---|---|
| New QT prolongation with worsening hypotension during MTP | Raises concern for low ionized calcium. Measure it promptly; if the patient is unstable and the result is not immediately available, follow the local protocol for treatment while testing proceeds. |
| Normal or mildly low total calcium | Does not reliably settle the acute question. Measure ionized calcium directly, especially during rapid transfusion or changing pH. |
| Reassuring PT/INR or other routine coagulation results | Does not replace an ionized-calcium measurement. Citrated coagulation samples are recalcified for testing, so they do not directly show the effect of the patient’s circulating calcium deficit. |
Do not wait for a chemistry panel’s total calcium if a rapid ionized result is available. Conversely, do not attribute hypotension to citrate just because the QT is long: ongoing hemorrhage, hypothermia, acidosis, myocardial dysfunction, medications, and other electrolyte problems can coexist.
Replace calcium, then recheck
For adults, a common trauma-protocol dose-equivalent pair is 1 g calcium chloride (10 mL of 10% solution) or 3 g calcium gluconate (30 mL of 10% solution). Use the institution’s MTP pathway and the patient’s ionized-calcium result to guide treatment and repeat dosing; product concentrations and local protocols matter.
If transfusion is ongoing, give calcium through separate IV/IO access whenever possible. Do not add it to a blood-product bag or administer it simultaneously through the blood administration tubing; calcium can counter citrate’s anticoagulant effect and allow clotting. If separate access is unavailable, follow the local transfusion protocol for pausing and thoroughly flushing the line before and after calcium administration.
Calcium chloride provides more elemental calcium in a smaller volume, but extravasation can cause serious tissue injury. Use a large, secure vein where possible, verify patency, and monitor the site. Calcium gluconate is an alternative, but it also requires secure IV access. Administer calcium slowly at a product- and protocol-appropriate rate with ECG and blood-pressure monitoring. The cited calcium chloride product label specifies slow infusion at no more than 1 mL/min; rapid administration can cause hypotension, bradycardia, dysrhythmia, syncope, or cardiac arrest.
After replacement, repeat ionized calcium and reassess the ECG and perfusion. If transfusion continues, the citrate load continues too, so one dose may not be the end of the problem. Some protocols use product-based redosing intervals; follow the local pathway and use serial measurements when available rather than assuming a single dose will cover the entire resuscitation.
Keep the evidence claim proportional: low ionized calcium is associated with worse outcomes in major bleeding, but that association does not prove that calcium replacement alone reduces mortality. Correct significant deficiency because it can impair cardiac function and hemostasis—not because it substitutes for hemorrhage control.
Calcium is not hemorrhage control
Continue MTP when it remains indicated, pursue source control, and reassess the patient’s whole physiology. If hypotension persists after ionized calcium is corrected, return to the differential: ongoing blood loss, tension pneumothorax, tamponade, cardiac dysfunction, hypothermia, and acidosis still need attention. Check potassium and magnesium as appropriate; transfusion-related electrolyte problems can overlap, and a QT interval alone does not identify every metabolic cause.
A shorter QT or improved pressure after calcium supports the working diagnosis, but it does not prove citrate toxicity was the sole cause. The safest mental model is parallel action: measure and correct ionized calcium while continuing hemorrhage resuscitation and looking for other reversible threats.
Practical takeaways
- During MTP, new QT prolongation with worsening hypotension should prompt an immediate ionized-calcium check.
- Citrate binds ionized calcium; rapid transfusion and impaired perfusion can let citrate accumulate faster than it is cleared.
- For adults, common dose-equivalent options are 1 g calcium chloride or 3 g calcium gluconate; follow local protocols and recheck ionized calcium.
- Prefer separate IV/IO access for calcium; do not put it in blood tubing. If no separate access is available, follow local pause-and-flush procedures.
- Monitor ECG, blood pressure, and the IV site during replacement—especially with calcium chloride—and follow product-appropriate administration rates.
- Calcium replacement complements, but never replaces, ongoing hemorrhage control and evaluation for other causes of shock.
